Navigation Links
Genmab Announces Upcoming Ofatumumab Studies
Date:8/25/2008

at least an objective response or stable disease during a 24 week treatment period of ofatumumab.Eligible patients will receive one infusion of ofatumumab at 300 mg followed by 7 once weekly infusions at 2000 mg. Maintenance treatment will consist of 24 once monthly infusions of 2000 mg of ofatumumab.The primary objective of this study is to estimate the proportion of objective responses over 52 weeks.

Phase II NHL ofatumumab retreatment and maintenance study This study will examine the retreatment and maintenance treatment of refractory follicular NHL patients who participated in the ongoing Phase III NHL study and had disease progression following at least 6 months objective response to or stable disease on ofatumumab.Eligible patients will receive one infusion of ofatumumab at 300 mg followed by 7 once weekly infusions at 1000 mg. Maintenance treatment will consist of one 1000 mg infusion every two months for two years.The primary objective of this study is to evaluate the safety of ofatumumab retreatment and maintenance treatment.

Phase I study in Japan This open-label study will include a maximum of 12 patients with relapsed/refractory follicular NHL and at least 1 CLL patient who will be divided into 2 cohorts of 3 or 6 patients each.Patients will receive one infusion of ofatumumab at 300 mg followed by seven weekly infusions of 500 or 1000 mg of ofatumumab.Safety at the 500 mg dose level of ofatumumab will be examined before progressing to the 1000 mg dose level.The primary objective of the study is to evaluate the safety and tolerability of ofatumumab in Japanese relapsed/refractory follicular NHL and CLL patients.The primary endpoint of the study is safety.

Ofatumumab is an investigational new generation human monoclonal antibody that targets a distinct, membrane proximal, small loop epitope (specific antibody binding site) of the CD20 molecule on B cells. Ofatumumab is being developed to treat chronic lymphocytic leukemia, follicular
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DAHANCA Initiates Head and Neck Cancer Study With Genmabs HuMax-EGFr
2. Bionomics Achieves US$1 Million Milestone Payment from Genmab
3. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
4. Genmab Announces Updates on Phase III Cancer Studies
5. Genmab A/S - Company Announcement Ofatumumab in Subcutaneous Study in Rheumatoid Arthritis Summary: Subcutaneous Administration of Ofatumumab Investigated in Phase I/II Study
6. Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer
7. Genmab Reaches Milestone in Ofatumumab Collaboration
8. Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study
9. Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)...  Air Products (NYSE: APD ) understands ... vital to any healthcare facility. This understanding has driven ... the efficiency of its oxygen supply systems, but also ... systems for emergency oxygen supply and high ... the 51 st ASHE Annual Conference & ...
(Date:7/28/2014)... Research and Markets  has announced the addition ... report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... to inflammation and pain in the human body,s joints such ... causes inflammation of the tissues that surround the joints and ... RA begin slowly, usually just mild pain around the joints ...
(Date:7/28/2014)... July 28, 2014  TNI BioTech, Inc. (OTCQB: ... focused on the development, marketing and distribution of ... definitive proxy materials with the Securities and Exchange ... of Shareholders to be held on Thursday, September ... The record date for determining those shareholders eligible ...
Breaking Medicine Technology:Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3Global Rheumatoid Arthritis Drugs Market 2014-2018 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3
... Institute and Gallo Research Center today announced ... (SoRI-9409) will be published in the December ... publication is available online,today at the journal,s ... that,causes selective and long-lasting reduction in ethanol ...
... ALTO, Calif., Sept. 11 Jazz,Pharmaceuticals, Inc. (Nasdaq: ... participation in the first Phase III pivotal clinical trial,of ... The JZP-6 Phase III clinical trial program includes two ... patients at 65 centers in the U.S. The second ...
Cached Medicine Technology:Novel Compound Shows Promise for Treatment of Alcoholism 2Novel Compound Shows Promise for Treatment of Alcoholism 3Novel Compound Shows Promise for Treatment of Alcoholism 4Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia 3
(Date:7/28/2014)... Co (PRWEB) July 28, 2014 Drorit ... has unveiled new plans to raise investment capital through ... 24/7 fitness concept in the United States. , According ... popularity of 24/7 fitness centers provide a great window ... this rapidly expanding space. In addition to this, Silverman ...
(Date:7/28/2014)... 2014 "Fist bumping" transmits significantly fewer bacteria ... the cultural expectation of hand-to-hand contact between patients ... the August issue of the American Journal ... the Association for Professionals in Infection Control and ... Institute of Biological, Environmental, and Rural Sciences at ...
(Date:7/28/2014)... 2014 The Wireline Services Market in Europe ... with analysis and forecast of revenue. The Wireline services market ... in 2013 to $2.4 billion by 2019, at a CAGR ... TOC of the Wireline Services Market in Europe report, to ... provides a glimpse of the segmentation in the European Wireline ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July ... to have a slightly increased risk of potentially fatal ... researchers report. Doctors have previously suspected that babies ... risk of deep vein thrombosis and pulmonary embolism, two ... the researchers noted in background information. This new ...
(Date:7/28/2014)... The Oneida Indian Nation today announced ... of accompanying PGA TOUR players will be teeing up ... Begay III for the seventh annual Notah Begay III ... Casino ’s Atunyote® Golf Club on Wednesday, August 27, ... Dufner, Jimmy Walker, Jonas Blixt, Angel Cabrera and Louis ...
Breaking Medicine News(10 mins):Health News:Pro Bodybuilder Drorit Silverman Confirms Plans to Raise Money for Investment in the Popular 24/7 Fitness Concept 2Health News:Fist-bumping beats germ-spreading handshake, study reports 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:Europe Wireline Services Market is Expected to Reach $2.4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 2Health News:Preemies May Have Higher Risk of Blood Clots, Even as Adults 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 2Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 3Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 4Health News:Turning Stone Announces that Tiger Woods and Fellow Golfing Elites Will Play at the Seventh Annual Notah Begay III Foundation Challenge 5
... , ... embrace new technology. , ... MA (PRWEB) January 11, 2010 -- SonRidge, LLC, a catering and chef supplies company located ... for their clients in the food industry. What they discovered was an innovative resolution that ...
... ... and marketer of all-natural sunscreen products launched their website at solaraegis.com. , ... (PRWEB) January 13, 2010 -- ... products launched their website at www.solaraegis.com ., , , , ,"The site ...
... ... and financial security pet health insurance makes sense. Veterinarians once skeptical to the value ... insurance. , ... PA (PRWEB) January 14, 2010 -- Pet Health Insurance in the United States and ...
... ... stresses importance of greater awareness of brain injuries and serious lifelong implications for victims ... San Francisco, ... Year,s Day, in which top-ranked American snowboarder Kevin Pearce suffered a severe brain injury ...
... led by Professor Eduardo Franco, Director of McGill University,s ... colleagues from McGill and Universit de Montral/Centre Hospitalier de ... per cent) of young adults in a new sexual ... nearly half (44 per cent) were infected with an ...
... , , , NEW YORK ... a leading provider of software to public retirement organizations, announced ... System implementation for the State Teachers Retirements System of ... as a replacement to their legacy contributions, pension, disbursement, and ...
Cached Medicine News:Health News:Insulated Transport Containers Go Green 2Health News:SolarAegis, LLC. Website Helps You Have Fun In the Sun, Safely 2Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 2Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 3Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 4Health News:Pet Health Insurance Grows as Pets Live Longer and Healthier Lives 5Health News:Snowboarding Accident Provides Tragic Reminder of Serious Risk of Brain Injuries in Athletic and Occupational Environments 2Health News:McGill-CHUM study: 56 percent of young adults in a new sexual relationship infected with HPV 2Health News:State Teachers Retirement System of Ohio Goes Live on V3 Benefits Administration System 2Health News:State Teachers Retirement System of Ohio Goes Live on V3 Benefits Administration System 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: